Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
World J Gastrointest Oncol ; 16(4): 1236-1247, 2024 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-38660650

RESUMEN

BACKGROUND: The efficacy and safety of transarterial chemoembolization (TACE) combined with lenvatinib plus programmed cell death protein-1 (PD-1) for unresectable hepatocellular carcinoma (HCC) have rarely been evaluated and it is unknown which factors are related to efficacy. AIM: To evaluate the efficacy and independent predictive factors of TACE combined with lenvatinib plus PD-1 inhibitors for unresectable HCC. METHODS: This study retrospectively enrolled patients with unresectable HCC who received TACE/lenvatinib/PD-1 treatment between March 2019 and April 2022. Overall survival (OS) and progression-free survival (PFS) were determined. The objective response rate (ORR) and disease control rate (DCR) were evaluated in accordance with the modified Response Evaluation Criteria in Solid Tumors. Additionally, the prognostic factors affecting the clinical outcome were assessed. RESULTS: One hundred and two patients were enrolled with a median follow-up duration of 12.63 months. The median OS was 26.43 months (95%CI: 17.00-35.87), and the median PFS was 10.07 months (95%CI: 8.50-11.65). The ORR and DCR were 61.76% and 81.37%, respectively. The patients with Barcelona Clinic Liver Cancer Classification (BCLC) B stage, early neutrophil-to-lymphocyte ratio (NLR) response (decrease), or early alpha-fetoprotein (AFP) response (decrease > 20%) had superior OS and PFS than their counterparts. CONCLUSION: This study showed that TACE/lenvatinib/PD-1 treatment was well tolerated with encouraging efficacy in patients with unresectable HCC. The patients with BCLC B-stage disease with early NLR response (decrease) and early AFP response (decrease > 20%) may achieve better clinical outcomes with this triple therapy.

2.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 31(1): 50-56, 2023 Feb.
Artículo en Chino | MEDLINE | ID: mdl-36765476

RESUMEN

OBJECTIVE: To discover the relationship between matrix remodeling associated 7 (MXRA7) and acute B lymphoblastic leukemia (B-ALL), and explore the effect of MXRA7 on the biological functions of B-ALL cell line REH. METHODS: The expression of MXRA7 in blood diseases was searched and analyzed through BloodSpot database. Real-time qPCR was used to detect the expression level of MXRA7 in B-ALL cell line 697 and REH cells. Lentivirus-mediated shRNA interference technology was utilized to knock down the expression of MXRA7 in REH cells. The effects of MXRA7 on the biological functions of REH cells were studied by in vitro experiments. Cell proliferation was detected by CCK-8 assay, cell cycle was detected by PI staining, cell apoptosis was detected by Annexin V and 7-AAD staining, and the expression of apoptosis pathway related proteins was detected by Western blot. RESULTS: Database analysis showed that MXRA7 was highly expressed in B-ALL patients, and real-time qPCR results showed that MXRA7 was also highly expressed in cell lines 697 and REH cells. Knockdown of MXRA7 in REH cells inhibited the cell proliferation and increased the percentage of G0/G1 phase cells. After treatment with cytarabine, the apoptotic ratio was increased in MXRA7-impaired REH cells, and the activation of caspase-3 and caspase-9 were also increased. CONCLUSION: Knockdown of MXRA7 can reduce the malignancy of REH cells by inhibiting the cell proliferation and increasing the sensitivity of REH cells to cytarabine. These results indicate MXRA7 may be as a novel target for the treatment of B-ALL, and the potential usefulness of MXRA7 in B-ALL deserves further investigation.


Asunto(s)
Leucemia-Linfoma Linfoblástico de Células Precursoras B , Leucemia-Linfoma Linfoblástico de Células Precursoras , Humanos , Apoptosis , Línea Celular Tumoral , Proliferación Celular , Citarabina , Leucemia-Linfoma Linfoblástico de Células Precursoras/metabolismo
3.
Zhongguo Shi Yan Xue Ye Xue Za Zhi ; 30(3): 688-694, 2022 Jun.
Artículo en Chino | MEDLINE | ID: mdl-35680791

RESUMEN

OBJECTIVE: To express matrix remodeling associated 7 (MXRA7) in the human acute myeloid leukemia SHI-1 cell line and to assess the role of MXRA7 in the biological function of SHI-1 cells. METHODS: The full-length cDNA sequence of human MXRA7 was synthesized and subcloned into the lentivirus shuttle vector pRRL-Venus. SHI-1 cells were transfected with the lentivirus which was packaged with 293T cells. The YFP-positive cells were sorted by flow cytometry and the stable cell lines were obtained by expanded culture. The expression and distribution of MXRA7 in SHI-1 cells were verified by real-time qPCR, Western blot and laser confocal techniques. Cell proliferation and cell cycle were measured by flow cytometry, and apoptosis was determined by Annexin V and 7-AAD staining. The expression of apoptosis related proteins were detected by Western blot. RESULTS: The stable SHI-1 cell line overexpressing MXRA7 was established successfully. Laser confocal analysis confirmed that MXRA7 was expressed in the cytoplasm of SHI-1 cells. Compared with the control cell line, the overexpression of MXRA7 showed no effect on the cell proliferation and cell cycle, but reduced the percentage of apoptosis cells induced by methotrexate. Moreover, the expression of BCL-2 protein was increased by overexpression of MXRA7, which can inhibit cell apoptosis. CONCLUSION: The SHI-1 stable cell line overexpressing MXRA7 was established successfully, and MXRA7 could inhibit drug-induced apoptosis through increasing the expression of BCL-2 protein.


Asunto(s)
Apoptosis , Proteínas de la Membrana/metabolismo , Proteínas Proto-Oncogénicas c-bcl-2 , Proteínas Reguladoras de la Apoptosis , Línea Celular Tumoral , Movimiento Celular , Proliferación Celular , Humanos , Proteínas Proto-Oncogénicas c-bcl-2/metabolismo
4.
Drug Des Devel Ther ; 13: 3343-3355, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-31571835

RESUMEN

OBJECTIVE: To investigate the effects of Chinese herb Danzhi Xiaoyao pills on the pharmacokinetics of venlafaxine and its metabolites O-desmethylvenlafaxine (ODV) and N-desmethylvenlafaxine (NDV) in beagles by using ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). METHODS: Six beagles (half male, half female) were chosen to test, being fasted before the experiment but having free access to drinking water 1 day before being fed drugs. After oral administration of venlafaxine hydrochloride tablets (10.28 mg/kg), the blood samples were collected in succession at different points in time. After 1-week washout period, Danzhi Xiaoyao pills (0.6g/kg) were given through oral administration to the six beagles every morning until the 7th day, venlafaxine hydrochloride tablets (10.28 mg/kg) were given after feeding Danzhi Xiaoyao pills (0.6g/kg) half an hour and blood samples were collected continuously at different points. All samples were analyzed by UPLC-MS/MS, and the main pharmacokinetic parameters of venlafaxine, ODV and NDV were computed by DAS 2.0. RESULTS: The Cmax of the venlafaxine group (control group) and the combination group (experimental group) were (2267.26±252.89) ng/mL and (1542.64±190.73) ng/mL, respectively. The AUC(0-∞) of the two groups were (13,934.79±3609.23) ng·h/mL and (8001.91±2167.58) ng·h/mL, respectively. The ODV Cmax of the two groups were (2253.80±215.81) ng/mL and (2721.37±118.20) ng/mL, and AUC(0-∞) were (13,974.99±2784.04) ng·h/mL and (17,539.44±1894.29) ng·h/mL, respectively. The NDV Cmax of the two groups were (50.98±5.76) ng/mL and (58.74±12.33) ng/mL, and AUC(0-∞) were (179.26±34.94) ng·h/mL and (220.68±51.41) ng·h/mL, respectively. After administration of Danzhi Xiaoyao pills, the Cmax and AUC(0-∞) of venlafaxine decreased significantly, indicating that the plasma exposure of venlafaxine decreased. The increase of Cmax and AUC(0-∞) of ODV and NDV indicated a rise in plasma exposure. CONCLUSION: Danzhi Xiaoyao pills can accelerate the metabolism of venlafaxine in beagles. In clinical, when venlafaxine was co-administrated with Danzhi Xiaoyao pills, dose adjustment of venlafaxine should be taken into account.


Asunto(s)
Medicamentos Herbarios Chinos/farmacología , Clorhidrato de Venlafaxina/farmacocinética , Animales , Área Bajo la Curva , Cromatografía Liquida , Ciclohexanoles/sangre , Ciclohexanoles/farmacocinética , Succinato de Desvenlafaxina/sangre , Perros , Medicamentos Herbarios Chinos/administración & dosificación , Femenino , Masculino , Comprimidos , Espectrometría de Masas en Tándem
5.
Huan Jing Ke Xue ; 34(4): 1351-6, 2013 Apr.
Artículo en Chino | MEDLINE | ID: mdl-23798113

RESUMEN

A total of 43 source water and finished water samples were collected from the Yangtze River and Taihu Lake in WX and SZ areas of Jiangsu Province from October 2010 to March 2012. The XAD-2 resin was applied to absorb the organic compounds in each water sample respectively. After the procedure of elution, concentration and drying, nonvolatile organic compounds (NVOCs) were obtained. The recombinant yeast estrogen screen test was then applied to evaluate the estrogenic activities of NVOCs in each water sample. The results showed that all of the source water collected from the Yangtze River and Taihu Lake possessed estrogenic activities. The EEQ values of source water from Taihu Lake were 0.04-2.07 ng x L(-1), and the volume of EC(25-E2) were 9.06-31.62 mL; the EEQ values of source water from Yangtze River were 0.69-1.15 ng x L(-1), and the volume of EC(25-E2) were 9.06-31.62 mL. The samples from Taihu Lake in SZ area had higher estrogenic activities than the samples collected from WX area. No estrogenic activity was detected in 58.3% of the finished water samples after the treatment in water plants. The water plants which collected source water from the Yangtze River and from Taihu Lake reduced the estrogenic activities by 80.3% -100% and 55.5% -100%, respectively.


Asunto(s)
Disruptores Endocrinos/análisis , Monitoreo del Ambiente , Estrógenos/análisis , Contaminantes Químicos del Agua/análisis , Abastecimiento de Agua/análisis , China , Lagos , Compuestos Orgánicos/análisis , Ríos
6.
J Huazhong Univ Sci Technolog Med Sci ; 33(1): 153-158, 2013 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-23392726

RESUMEN

Thrombus disease, one of the common cardiovascular diseases, has attracted worldwide attention for its rising mortality and morbidity. Due to the distinct shortages of current fibrinolytic drugs, new fibrinolytic agents warrant investigation. In this study, 8 fibrinolytic enzyme-producing strains were isolated from Douchi-a traditional Chinese food, and strain XY-1 which produced the largest amount of the enzyme was chosen for the following experiments. The enzyme produced by strain XY-1 was named Douchi fibrinolytic enzyme (DFE). We optimized the liquid culture medium of strain XY-1 for enzyme production using Plackett-Burman and Box-Behnken design. The predicted maximal DFE yield was 19.78 FU/mL with 11.4 g/L peptone, 0.5 g/L magnesium sulfate and 1 g/L sodium chloride. However, we acquired maximal production of 21.33 FU/mL in actual experiments, equal to 107.84% of the theoretical value, and the yield had been increased by 79.55% as compared to the yield of un-optimized culture. It was demonstrated that the combined use of Plackett-Burman design and response surface methodology in fermentation optimization can effectively and rapidly increase DFE production.


Asunto(s)
Bacillus/fisiología , Coagulación Sanguínea/efectos de los fármacos , Fabaceae/enzimología , Fibrinolíticos/metabolismo , Fibrinolíticos/farmacología , Modelos Estadísticos , Reactores Biológicos/microbiología , Coagulación Sanguínea/fisiología , Células Cultivadas , Técnicas Químicas Combinatorias , Simulación por Computador , Fabaceae/crecimiento & desarrollo , Fabaceae/microbiología , Fibrinolíticos/aislamiento & purificación , Humanos , Modelos Biológicos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA